Beta Bionics Inc

BBNXNASDAQ · USD
13.85USD-0.87 (-5.91%)
357

Beta Bionics Inc (BBNX) Covered Calls

Beta Bionics Inc trades in the Medical Devices industry with an IV Rank of 63.89%, average versus the past year. BBNX's highest covered call setup is the $30.00 strike expiring Apr 16, 2027, sorted by theoretical annualized return. It's 103.80% out of the money with 150 days to expiration, a 106.86% return until expiration, and a 260.03% theoretical annualized return. Across the setups shown, annualized returns run from 32.78% to 260.03% at strikes between $15.00 and $30.00, with 31 to 150 days to expiration, as of Nov 17, 2026.

Read more

Running BBNX covered calls helps you generate income from Beta Bionics Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best BBNX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If BBNX stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling BBNX covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given BBNX covered call is worth writing.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.

2027-04-1615030.00103.800.453.901573.00106.86260.03-3.06+0.3723.45
2027-04-1615020.0035.870.404.50568.0038.5993.89-2.72+0.46154.10
2026-12-183115.001.900.254.4053.003.6042.39-1.70+0.5704.15
2027-04-1615015.001.901.805.20208.0014.1334.38-12.23+0.6213.40
2027-01-155915.001.900.504.5078.005.3032.78-3.40+0.582904.00

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank63.89% Moderate
  • Market cap (M$)800
  • 52 weeks high-55.00%
  • 52 weeks low67.27%
  • Analyst recommendationBuy
    1.60
  • Target price$25.10
    81.23% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2027-02-16
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.85
  • EPS growth next 5 years4.23%

As of Nov 17, 2026